The proposed bill would update current statutes by granting pharmacists the authority to independently test for and treat specific health conditions, such as influenza, group A streptococcus pharyngitis, and COVID-19, under protocols approved by the Arizona State Board of Pharmacy. It establishes the Independent Testing and Treatment Advisory Committee to aid in protocol development and outlines pharmacists' responsibilities, including documentation, patient referrals, and record-keeping. The bill also specifies that pharmacists are not obligated to provide these services and protects their autonomy from employer interference.

Additionally, the bill introduces provisions for pharmacists to initiate and dispense HIV preexposure and postexposure prophylaxis (PrEP and PEP), requiring them to conduct necessary tests, assess contraindications, and provide counseling. It sets minimum training requirements for pharmacists in these areas, mandates professional liability insurance, and emphasizes patient privacy during testing and treatment. The bill aims to enhance pharmacists' roles in public health while ensuring compliance with established guidelines and maintaining patient safety.

Statutes affected:
House Engrossed Version: 32-1979.04, 32-1979.05, 32-1979.06
Chaptered Version: 32-1979.04, 32-1979.05, 32-1979.06